Illumina sends letter to shareholders detailing why illumina's nominees far outmatch icahn's slate in skills and experience

Illumina's director nominees bring deep commercial, scientific and business experience from leading organizations including microsoft, symantec, and medco-ubc leading proxy advisory firm iss has recommended illumina shareholders vote for illumina ceo francis desouza and board member robert epstein icahn's associates bring zero relevant experience and zero independence illumina requests shareholders to vote the white proxy card today for all nine of illumina's director nominees annual meeting will be held virtually on may 25, 2023, at 10:00 am pacific time (1:00 pm eastern time) for more information, visit www.illuminaforward.com san diego , may 15, 2023 /prnewswire/ -- illumina (nasdaq: ilmn), a global leader in dna sequencing and array-based technologies, today issued a shareholder letter outlining the purpose-built mix of skills illumina's nominees bring to the board compared to carl icahn's unqualified associates, each of whom lack relevant experience and independence. institutional shareholder services ("iss"), a leading independent proxy voting and corporate governance advisory firm, recommends illumina shareholders vote for illumina ceo francis desouza and board member robert epstein.
IEP Ratings Summary
IEP Quant Ranking